Navigation Links
Meta-Analysis of SYMLIN(R) Clinical Data Showed No Increased Risk of Cardiovascular Adverse Events Associated With SYMLIN Treatment in Patients With Type 2 Diabetes
Date:6/26/2010

loped and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) injection. Amylin's research and development activities leverage the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California. Further information on Amylin Pharmaceuticals is available at http://www.amylin.com.

This press release contains forward-looking statements about Amylin, which involve risks and uncertainties. The Company's actual results could differ materially from those discussed due to a number of risks and uncertainties, including that our clinical trials may not start when planned and/or confirm previous results; the meta-analysis described in this press release may not be predictive of real world experience; our product candidates may not receive regulatory approval; and inherent scientific, regulatory and other risks in the drug development and commercialization process; SYMLIN and the SymlinPen, and the revenues generated from these products, may be affected by competition, unexpected new data, technical or safety issues, or manufacturing and supply issues. Commercial and government reimbursement and pricing decisions and the pace of market acceptance may also affect the potential for SYMLIN and the SymlinPen. These and additional risks and uncertainties are described more fully in the Company's most recently filed SEC documents, including its Form 10-Q. Amylin undertakes no duty to update these forward-looking statements.

(i) Diabetes Statistics. American Diabetes Association. Available at

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Corgenix Receives Additional European Patent, Announces Publication of Important Clinical Study on AtherOx(R) Technology
2. Pieris Initiates Phase I Clinical Trial for Lead Anticalin Compound
3. Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study
4. Stemedica Announces the Appointment of Dr. Lev Verkh as Chief Regulatory and Clinical Development Officer
5. Open Source Clinical Trials Software Featured at the 46th DIA Annual Meeting
6. Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting
7. New Cancer Treatments and Combination Therapies Presented by Leading Experts from the John Theurer Cancer Center at the American Society of Clinical Oncology Annual Meeting
8. NewLink Initiates Pivotal Phase 3 Clinical Trial of HyperAcute(R)-Pancreas Immunotherapy for Resected Pancreatic Cancer
9. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial
10. Dendreon Announces Presentation of PROVENGE Data at the American Society of Clinical Oncology Annual Meeting
11. Nexavar Data to be Presented at 46th American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... (PRWEB) June 18, 2013 The ... opening of two new offices in Asia—one in Singapore ... will serve as RAPS’ Pan-Asia office , serving ... be more focused on audiences within China. , The ... its partnership with five Singapore government agencies to develop ...
(Date:6/18/2013)... JERUSALEM , June 18, 2013 ... study using the company,s  proprietary AMCA Guided Bone Regeneration (GBR) ... dental implants. A common problem encountered when patients ... lack of sufficient bone volume to house the implant. Consequently ... a bone substitute until the natural bone regenerates. The bone ...
(Date:6/18/2013)... The "Bioinformatics Market By Sector (Molecular Medicine, ... & Data Analysis Services) & Application (Genomics, Proteomics & Drug ... Drivers, Restraints, and Opportunities in North America ... and Rest of World. Browse ... 22 Figures 364 Pages and an ...
(Date:6/18/2013)... June 18, 2013 ... announced the addition of the "Injectable ... & Nanoparticles], Devices [Disposables & Reusable, Fillable ... Injectors] & Therapeutics [Diabetes & Oncology] - ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ...
Breaking Biology Technology:RAPS Opens Offices in Singapore and China 2RAPS Opens Offices in Singapore and China 3RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3
... Expands Beckman Coulter,s Worldwide Position in Clinical ... in Chemistry and Automation Broaden Global Opportunity, ... Penetration of Beckman Coulter,s Immunoassay Products into ... Growth- Transaction Expected to be Accretive to ...
... MMR Information Systems, Inc. (OTC Bulletin ... subsidiary, MyMedicalRecords, Inc. (collectively, "MMR") provides consumer-controlled ... and electronic safe deposit box storage solutions ... investment banking firm Houlihan Smith & Co. ...
... Pa., Feb. 26 Globus Medical, Inc., the ... world, today announced the full launch of its ... a MILDER (TM) Anterior Lumbar Interbody Fusion ... interbody spacer into a preassembled, easy-to-use system that ...
Cached Biology Technology:Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation 2Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation 3Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation 4Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation 5Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation 6MMR Information Systems, Inc. Engages Houlihan Smith 2MMR Information Systems, Inc. Engages Houlihan Smith 3Globus Medical's INDEPENDENCE(TM) Spacer System: The MILDER(TM) ALIF Solution 2
(Date:6/17/2013)... their food may turn out to be just as important ... of St. Michael,s Hospital. , The study, led by ... association between poor eating habits in kids ages three to ... cholesterol, putting them at risk for cardiovascular disease later in ... Medical Association Journal today. , "We know that ...
(Date:6/17/2013)... ST. LOUIS -- In research published in Biochemical ... describe a technology that can detect new, previously unknown ... for viruses even when doctors have not identified a ... , In the new approach, scientists use ... discover viruses. , Taking advantage of the complete deciphering ...
(Date:6/17/2013)... As mobile devices, smartphones and tablets ... grows exponentially, and biometric authentication offers that security, ... Reading Insider ( www.heavyreading.com/mobile-networks ), a subscription ... www.heavyreading.com ). Biometrics Offer Promise for ... authentication on smartphones, analyzing the most lucrative verticals ...
Breaking Biology News(10 mins):Poor eating behaviors may put preschoolers at risk for later health problems 2Saint Louis University researchers discover a way to detect new viruses 2Saint Louis University researchers discover a way to detect new viruses 3Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 3
... a chunk of its tail fin, it'll grow back within ... replace surprisingly complex body parts. A tail fin, for example, ... intricate structure. It is the fish version of an arm ... missing tails and other appendages has fascinated veterinary and medical ...
... at the University of Georgia, using glow-in-the-dark proteins ... function of a complex organelle in the bacterium ... described in new, precise detail the unique cell ... bacterium Mycoplasma pneumoniae. This structure, called a "terminal ...
... deep within the cells of fruit flies, developmental biologists ... in Philadelphia may have discovered a new way that ... they're right, and the same processes are at work ... have implications for improving the understanding of a range ...
Cached Biology News:How does a zebrafish grow a new tail? 2How does a zebrafish grow a new tail? 3UGA scientists unravel 'molecular inch-worm' structure of walking-pneumonia bacterium 2Jefferson researchers uncover new way nature turns genes on and off 2
... Fujifilm Life Science LAS-3000 imaging system ... a simplified user interface, providing significantly ... range of modularities. The system is ... the perfect standard system for Western ...
... Science LAS-3000mini is a compact image ... applications, and the perfect standard system ... LAS-3000 provides significantly improved system sensitivity ... calibration standards validate that Fujis LAS-3000 ...
... kit provides complete components including positive and ... DNA fragmentation in cultured cells and tissue ... of apoptotic cells. Internucleosomal DNA ... mammalian cells. MBLs ApoDIRECT In Situ DNA ...
SDS-OutT Precipitation Reagent...
Biology Products: